Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page shows a new revision label 'Revision: v3.3.4', replacing the previous 'v3.3.3', with no observed changes to core content, eligibility criteria, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:40:00.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer notes now show Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.
    Difference
    0.1%
    Check dated 2025-12-23T22:37:33.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed. This update does not modify the study details, eligibility criteria, endpoints, or other substantive content on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:47:45.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Removed the government funding/operating-status notice at the top of the page; no core study data or critical content were altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:23:32.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The study details page shows no significant updates; core information including eligibility criteria and primary outcomes appears unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:02:43.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Version bump to v3.2.0 accompanied by a government-operating-status notice; replaces the earlier v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-06T08:58:05.000Z thumbnail image

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.